Prognostic factors of children’s acute lymphoblastic leukemia therapy in Moscow—Berlin protocols
Проанализирована значимость прогностических факторов эффективности терапии у детей с острым лимфобластным лейкозом (ОЛЛ), получающих терапию по протоколу ALL-MB-2002, в зависимости от группы риска. В исследование были включены 1544 первичных больных ОЛЛ в возрасте от 1 года до 18 лет, получавших леч...
Saved in:
| Main Authors: | J. V. Roumiantseva, A. I. Karachunsky, O. V. Aleinikova, L. G. Fechina, A. V. Schamardina, D. V. Litvinov, N. I. Ponomareva, E. G. Boichenko, L. V. Sidorenko, S. A. Dudkin, O. V. Streneva, K. L. Kondratchik, E. G. Mansurova, L. M. Minkina, E. S. Lapotentova, E. V. Inuschkina, N. B. Yudina, G. P. Pavlova, E. V. Zhukovskaya, O. P. Chlebnikova, S. N. Lagoiko, E. V. Bascharova, R. E. Denisov, V. D. Zlobina, E. S. Banschikova, K. S. Aslanyan, E. V. Kondakova, E. V. Celousova, N. V. Myakova, T. V. Turobova, O. V. Riskal, N. F. Chipsanova, S. R. Varfolomeeva, A. G. Rumiantsev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-11-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/659 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of three various chemotherapy protocols for acute lymphoblastic leukemia BFM-90m, MB-91 and PECO-92 in Moscow and St.-Petersburg
by: E. G. Boichenko, et al.
Published: (2022-11-01) -
Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia
by: A. N. Sokolov, et al.
Published: (2015-06-01) -
Combined chemoimmunotherapy of patients with mature B-cell non-Hodgkin lymphomas age group until 18 years: results of multicenter study NHL 2004 m with rituximab and modified B-NHL BFM 90 protocol applications
by: E. V. Samochatova, et al.
Published: (2022-11-01) -
Optimization of native E. coli-asparaginase therapy in standard risk-group children with acute lymphoblastic leukemia treated by the ALL-MB 2002 protocol
by: M. Yu. Goroshkova, et al.
Published: (2022-11-01) -
Approaches to improvement of treatment results of malignant tumors in adolescents and young adults
by: A. G. Rumyantsev, et al.
Published: (2014-07-01)